News blog
Promising signs emerging from HIV gene therapy trials
Although primarily designed to assess safety and feasibility of the treatment developed by Sangamo BioSciences, the Phase I trials, coupled with results from other basic and animal studies, have several AIDS experts talking tentatively about the possibility of a cure for the disease, something that scientists and clinicians have avoided since disappointments in the mid 1990s. “Cure has been a four letter word,” says Steven Deeks a clinical researcher at the University of California San Francisco, who has patients enrolled in one of the trials.
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells